1. Benzodiazepines and hip fractures in the elderly

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Precipitation of teniposide solutions

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Viral encephalitis may influence benzodiazepine withdrawal

   Newsletter Article 27 January 2013 Pages: 1 - 1

4. The indiscriminant use of aspirin should be discouraged

   Newsletter Article 27 January 2013 Pages: 2 - 2

5. Heparin and thrombopenia/thrombosis: problems and possible solutions

   Newsletter Article 27 January 2013 Pages: 2 - 4

6. Antibacterials

   Newsletter Article 27 January 2013 Pages: 4 - 4

7. Antineoplastics

   Newsletter Article 27 January 2013 Pages: 4 - 4

8. Aspirin

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Azathioprine see Cyclophosphamide/azathioprine

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Bleomycin

    Newsletter Article 27 January 2013 Pages: 4 - 5

11. Carbamazepine

    Newsletter Article 27 January 2013 Pages: 5 - 5

12. Carbamazepine/lithium

    Newsletter Article 27 January 2013 Pages: 5 - 5

13. Chlorhexidine

    Newsletter Article 27 January 2013 Pages: 5 - 5

14. Chlorphenamine

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Clozapine

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Cocaine abuse

    Newsletter Article 27 January 2013 Pages: 6 - 6

17. Colchicine see Cyclosporin/colchicine

    Newsletter Article 27 January 2013 Pages: 6 - 6

18. Contrast media

    Newsletter Article 27 January 2013 Pages: 6 - 6

19. Coumarin

    Newsletter Article 27 January 2013 Pages: 6 - 6

20. Cyclophosphamide/azathioprine

    Newsletter Article 27 January 2013 Pages: 6 - 6

21. Cyclosporin/colchicine

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Diazoxide

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Diethylstilbestrol

    Newsletter Article 27 January 2013 Pages: 6 - 6

24. Dihydroergotamine interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

25. Diphtheria tetanus and pertussis vaccine

    Newsletter Article 27 January 2013 Pages: 7 - 7

26. Disulfiram

    Newsletter Article 27 January 2013 Pages: 7 - 7

27. Droperidol

    Newsletter Article 27 January 2013 Pages: 7 - 7

28. Equine rabies immune globulin

    Newsletter Article 27 January 2013 Pages: 7 - 7

29. Gentamicin

    Newsletter Article 27 January 2013 Pages: 7 - 7

30. Heparin

    Newsletter Article 27 January 2013 Pages: 7 - 7

31. Heparin see Pentosan polysulfate/heparin

    Newsletter Article 27 January 2013 Pages: 7 - 7

32. Hyaluronic acid

    Newsletter Article 27 January 2013 Pages: 7 - 8

33. Ibuproxam

    Newsletter Article 27 January 2013 Pages: 8 - 8

34. Insulin human

    Newsletter Article 27 January 2013 Pages: 8 - 8

35. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 8 - 8

36. Interleukin 2 ± LAK cells

    Newsletter Article 27 January 2013 Pages: 8 - 8

37. Isoprenaline see Theophylline interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

38. LAK cells see Interleukin 2 ± LAK cells

    Newsletter Article 27 January 2013 Pages: 8 - 8

39. Lithium

    Newsletter Article 27 January 2013 Pages: 8 - 8

40. Lithium see Carbamazepine/lithium

    Newsletter Article 27 January 2013 Pages: 8 - 8

41. Loperamide poisoning

    Newsletter Article 27 January 2013 Pages: 9 - 9

42. Mercaptopurine

    Newsletter Article 27 January 2013 Pages: 9 - 9

43. Nifedipine

    Newsletter Article 27 January 2013 Pages: 9 - 9

44. Nifedipine

    Newsletter Article 27 January 2013 Pages: 9 - 9

45. Olsalazine

    Newsletter Article 27 January 2013 Pages: 9 - 9

46. Oral contraceptives

    Newsletter Article 27 January 2013 Pages: 9 - 9

47. Paracetamol interaction

    Newsletter Article 27 January 2013 Pages: 9 - 9

48. Penicillamine

    Newsletter Article 27 January 2013 Pages: 9 - 10

49. Pentosan polysulfate/heparin

    Newsletter Article 27 January 2013 Pages: 10 - 10

50. Poliovirus vaccine live oral

    Newsletter Article 27 January 2013 Pages: 10 - 10